Key result
Among nearly 114,000 Czech patients undergoing pacemaker implantation, 5-year overall survival was 60.6% and 10-year overall survival was 32.7%, representing higher mortality than the general population.
Why the study?
The study aimed to analyze mortality from national health registries and the REPACE central registry in Czech patients undergoing pacemaker implantation.
Observational (n=114,000)
Yes
In a nationwide Czech registry of nearly 114,000 patients, pacemaker implantation was associated with a 5-year overall survival of 60.6%, reflecting higher mortality than the general population.
Increasing Czech pacemaker implantations observed; leaves open mortality associations and optimal device selection in observational data.
Background and aims: Analysis of mortality from the national health registries and data from a specific central registry dealing with the implantation of pacemakers (REPACE) in Czech patients. Methods and results: 10.4 years old] between 2010 and 2021. Almost 114,000 pacemakers were implanted between 2010 and 2021, of which 27.9% were single-chamber, 67.4% were dual-chamber and 4.6% were biventricular. The annual number of implantations has been steadily increasing with a 6% annual decline in 2020 with increased mortality and reductions in care provided, likely related to COVID-19. The observed 5-year relative survival was 88.6% (overall survival 60.6%) and the 10-year relative survival was 75.9% (overall survival 32.7%). Causes of death 5ary according to the age of the patient. The highest difference 1n the reported numbers in the REPACE Registry did not exceed 2% in comparison with the National Register of Reimbursed Health Services. Conclusion: This study followed all Czech patients with pacemaker's implantation in between 2010 and 2021. The annual number of 1mplantations has been steadily 1ncreasing. Patients with implanted pacemakers had a significantly higher mortality than the average population. Number of patients in the registry corresponded almost perfectly with the National Register of Reimbursed Health Services.
No takes yet. Share an insight, caveat, or question.
Táborský et al. (2023) conducted an observational in Pacemaker implantation (n=114,000). Pacemaker implantation vs. Average population was evaluated on 5-year overall survival. Among nearly 114,000 Czech patients undergoing pacemaker implantation, 5-year overall survival was 60.6% and 10-year overall survival was 32.7%, representing higher mortality than the general population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: